The study was funded by the Ruth L. Kirschstein Predoctoral Fellowship (T32) from the National Institute of Mental Health. The funding sources had no role in the study's design, conduct, and reporting. The authors thank Andrew Nierenberg, M.D., Ph.D., Nancy Keating, M.D., M.S., Richard G. Frank, Ph.D., and Joseph P. Newhouse, Ph.D., for comments and suggestions.
Dr. Cutler reports being on the speaker's bureaus of Coresource, Chaindrugstore.net, Health Care Financial Management Association, IMS, MedImpact, Medtronic, National Association of Chain Drug Stores, Senate President's Forum, Society of Actuaries, Thomson-Reuters, and U.S. Oncology. He has also been on the advisory board of Genentech. The other authors report no competing interests.